Cyproterone Ethinylestradiol

Antiacneic Cyproterone Ethinylestradiol

Cyproterone ethinylestradiol is prescribed in the case of treatment of the women acne, as antiacneic hormonal. This association is composed of cyproterone acetate, an anti-steroidal, and ethinylestradiol, an estrogen. This allows to oppose the action of androgen hormones, and thus reduce the production of sebum, partly responsible in women acne.

Hormonal Treatment Cyproterone Ethinylestradiol

This treatment is available only for women. The cyproterone acetate 2mg coupled to the ethinylestradiol 35 micrograms is effective in the medium and minor acne. However, the activity is slower to appear, it takes about 6 months. The cyproterone acetate reduces sebum excretion of 30% as a result of its central and peripheral antiandrogenic activity. The contraceptive effect of the association Cyproterone ethinylestradiol is accepted but not validated, so that health authorities have not recommended their use for this purpose among women receiving isotretinoin. It is very important to respect prescribed doses, an overdose can cause vomiting and nausea.

Contraindications Cyproterone ethinylestradiol

In case of pregnancy or breastfeeding, Cyproterone ethinylestradiol is particularly banned, as in the man and the child. In case of prescription, a biological and medical watch should be carried out regularly. Despite its contraceptive effect recognized, Cyproterone ethinylestradiol should not be used as such. In case of varicose veins, asthma, symptoms of epilepsy, diabetes or renal failure, unexplained genital bleeding, it is imperative to contact a doctor as soon as possible. In cases of severe liver damage, cancer of the uterus or breast declared, heart weakness, hypertention, a history of myocardial infarction or stroke (Cerebral Vascular Accident), the use of the association cyproterone ethinylestradiol is totally inappropriate.

Side effects cyproterone-ethinylestradiol

The prescription of this drug combination can cause a surge artery or coronary problems, but it can also entail significant cardiac complications, arterial thrombosis (myocardial infarction, cerebrovascular accident (AVC)), or even venous like phlebitis or pulmonary embolism.

Interactions drug cyproterone ethinylestradiol

In case of Ritovanir taken, prescription of cyproterone ethinylestradiol is to be avoided, because it reduces the effectiveness. In the case of smoking, it is necessary to avoid as much as possible to administer, it is strongly disadvised to associate tobacco and cyproterone-ethinylestradiol. Products tend to decrease the effectiveness of the association cyproterone-ethinylestradiol, like those of the family of anticonvulsants. Finaly, interactions are possible with the flunarizine or cyclosporine, we must take care to prevent his doctor in case of cumulative taking of different medications.